Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab

Código QR

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab

Kei Takayama,1 Tosio Enoki,1,2 Teruo Kojima,1,2 Sho Ishikawa,1 Masaru Takeuchi,11Department of Ophthalmology, National Defense Medical College, Saitama, Japan; 2Enoki Clinic, Saitama, JapanAbstract: Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is a rare disorder that sometimes causes s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Takayama K, Enoki T, Kojima T, Ishikawa S, Takeuchi M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/8fba179c7cf24da7ac04db006062dcef
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Intravitreal ranibizumab in treating extensive traumatic submacular hemorrhage
por: Abdul-Salim I, et al.
Publicado: (2013)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: R Prince Davis, et al.
Publicado: (2010)

Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
por: Bhurayanontachai P, et al.
Publicado: (2011)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban AA, et al.
Publicado: (2012)

Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia
por: Rouvas A, et al.
Publicado: (2013)

Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
por: Sukhpal Singh Sandhu, et al.
Publicado: (2010)

Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection
por: Kugu S, et al.
Publicado: (2012)

Evaluation of intraocular pressure elevation after multiple injections of intravitreal ranibizumab
por: Yu AL, et al.
Publicado: (2014)

Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection
por: Fujii A, et al.
Publicado: (2014)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
por: Suzuki H, et al.
Publicado: (2017)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis D, et al.
Publicado: (2017)

Use of nepafenac (Nevanac&reg;) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections
por: Eric Chen, et al.
Publicado: (2010)

A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis
por: Singh RP, et al.
Publicado: (2015)

Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation
por: Negi A, et al.
Publicado: (2012)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
por: Jos&eacute; M&ordf; Ruiz-Moreno, et al.
Publicado: (2008)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Shatriah I, et al.
Publicado: (2011)

Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration
por: Nishimura T, et al.
Publicado: (2012)

A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum]
por: Singh RP, et al.
Publicado: (2017)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon S, et al.
Publicado: (2014)

Lucentis&reg; using Visudyne&reg; study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration
por: Eric Chen, et al.
Publicado: (2010)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim M, et al.
Publicado: (2013)

Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity
por: Arámbulo O, et al.
Publicado: (2015)

Intravitreal gas injection for the treatment of diabetic macular edema
por: McHugh D, et al.
Publicado: (2011)

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
por: Antonopoulos C, et al.
Publicado: (2011)

Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats’ Disease
por: Nowara M, et al.
Publicado: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda SM, et al.
Publicado: (2017)

Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size
por: Fujihara M, et al.
Publicado: (2012)

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
por: Williams PD, et al.
Publicado: (2012)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
por: Miura M, et al.
Publicado: (2013)

Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life
por: Inoue M, et al.
Publicado: (2014)

The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing
por: Christoforidis JB, et al.
Publicado: (2013)

Crystallization after intravitreal ganciclovir injection
por: Pitipol Choopong, et al.
Publicado: (2010)

Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients
por: Yamamoto A, et al.
Publicado: (2013)

Evaluation of the effect of intravitreal ranibizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness using optical coherence tomography
por: El-Ashry MF, et al.
Publicado: (2015)

Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium
por: Hurmeric V, et al.
Publicado: (2013)

Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma
por: Canut MI, et al.
Publicado: (2011)

Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema
por: Saeed AM
Publicado: (2013)

Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
por: Houston SK, et al.
Publicado: (2013)

Case of endophthalmitis following intravitreal injections of bevacizumab
por: Shinya Komori, et al.
Publicado: (2010)

Low-dose aspirin as treatment for central serous chorioretinopathy
por: Antonio Caccavale, et al.
Publicado: (2010)